Apyx Medical Future Growth
Future criteria checks 1/6
Apyx Medical is forecast to grow earnings and revenue by 32% and 7.7% per annum respectively while EPS is expected to grow by 35% per annum.
Key information
32.0%
Earnings growth rate
35.0%
EPS growth rate
| Medical Equipment earnings growth | 14.2% |
| Revenue growth rate | 7.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 52 | -14 | -5 | N/A | 4 |
| 12/31/2025 | 48 | -17 | -13 | N/A | 4 |
| 12/31/2024 | 47 | -25 | -20 | N/A | 4 |
| 9/30/2024 | 49 | -28 | -18 | -17 | N/A |
| 6/30/2024 | 49 | -28 | -10 | -9 | N/A |
| 3/31/2024 | 50 | -23 | -10 | -10 | N/A |
| 12/31/2023 | 52 | -19 | -6 | -5 | N/A |
| 9/30/2023 | 50 | -15 | -8 | -8 | N/A |
| 6/30/2023 | 47 | -16 | -17 | -17 | N/A |
| 3/31/2023 | 44 | -21 | -18 | -18 | N/A |
| 12/31/2022 | 45 | -23 | -21 | -20 | N/A |
| 9/30/2022 | 49 | -19 | -17 | -16 | N/A |
| 6/30/2022 | 51 | -18 | -15 | -14 | N/A |
| 3/31/2022 | 52 | -16 | -14 | -13 | N/A |
| 12/31/2021 | 49 | -15 | -11 | -10 | N/A |
| 9/30/2021 | 43 | -15 | -12 | -12 | N/A |
| 6/30/2021 | 38 | -14 | -11 | -11 | N/A |
| 3/31/2021 | 31 | -15 | -11 | -11 | N/A |
| 12/31/2020 | 28 | -12 | -17 | -16 | N/A |
| 9/30/2020 | 25 | -16 | -19 | -18 | N/A |
| 6/30/2020 | 25 | -16 | -21 | -20 | N/A |
| 3/31/2020 | 28 | -16 | -22 | -21 | N/A |
| 12/31/2019 | 28 | -20 | -20 | -18 | N/A |
| 9/30/2019 | 26 | -18 | -35 | -33 | N/A |
| 6/30/2019 | 22 | -15 | -30 | -30 | N/A |
| 3/31/2019 | 19 | -14 | -25 | -25 | N/A |
| 12/31/2018 | 17 | -11 | -21 | -21 | N/A |
| 9/30/2018 | 14 | -10 | -2 | -2 | N/A |
| 6/30/2018 | 13 | -12 | N/A | -1 | N/A |
| 3/31/2018 | 5 | -15 | N/A | -2 | N/A |
| 12/31/2017 | 10 | -14 | N/A | -4 | N/A |
| 9/30/2017 | -12 | -19 | N/A | -5 | N/A |
| 6/30/2017 | -4 | -17 | N/A | -4 | N/A |
| 3/31/2017 | 37 | -4 | N/A | -3 | N/A |
| 12/31/2016 | 9 | -12 | N/A | -3 | N/A |
| 9/30/2016 | 35 | -5 | N/A | -3 | N/A |
| 6/30/2016 | 33 | -5 | N/A | -4 | N/A |
| 3/31/2016 | 31 | -6 | N/A | -6 | N/A |
| 12/31/2015 | 30 | 8 | N/A | -6 | N/A |
| 9/30/2015 | 29 | 4 | N/A | -5 | N/A |
| 6/30/2015 | 28 | 3 | N/A | -3 | N/A |
| 3/31/2015 | 27 | 4 | N/A | -1 | N/A |
| 12/31/2014 | 28 | -18 | N/A | 0 | N/A |
| 9/30/2014 | 26 | -18 | N/A | -2 | N/A |
| 6/30/2014 | 25 | -15 | N/A | -3 | N/A |
| 3/31/2014 | 24 | -16 | N/A | -3 | N/A |
| 12/31/2013 | 24 | -7 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BOV is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BOV is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BOV is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BOV's revenue (7.7% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: BOV's revenue (7.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BOV's Return on Equity is forecast to be high in 3 years time